Tissue Inhibitor of Metalloproteinases-3 Inhibits Shedding of L-selectin from Leukocytes*

  1. Gillian Borland,
  2. Gillian Murphy and
  3. Ann Ager§
  1. From the Division of Cellular Immunology, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, and theSchool of Biological Sciences, University of East Anglia, Norwich, Norfolk, NR4 7TJ, United Kingdom

    Abstract

    Although the enzyme or enzymes mediating shedding of L-selectin have not yet been identified, this activity can be blocked by synthetic hydroxamic acid-based inhibitors of metalloproteinases such as Ro 31-9790. However, the endogenous matrix metalloproteinase inhibitor tissue inhibitor of metalloproteinases (TIMP)-1 does not block L-selectin shedding. Here, we report that TIMP-3, but not TIMP-2, inhibits L-selectin shedding from mouse and human lymphocytes, Jurkat T cells, and human monocytes. TIMP-3 has an IC50 of 0.3–0.4 μm on these cell types compared with 0.7–4.8 μm for Ro 31-9790. A metalloproteinase (tumor necrosis factor-α (TNF-α)-converting enzyme; ADAM17) has recently been identified which cleaves the pro-form of TNF-α to produce soluble cytokine. We compared inhibition of L-selectin shedding by TIMPs and Ro 31-9790 with inhibition of TNF-α shedding from human monocytes. TIMP-3 inhibited TNF-α shedding (IC50 of 0.1 μm), as did Ro 31-9790 (IC50 of 0.4 μm). TIMP-2 had a partial effect, and TIMP-1 did not inhibit. This study confirms that L-selectin sheddase is a metalloproteinase, but not a matrix metalloproteinase, and investigates the relationship between shedding of L-selectin and TNF-α.

    Footnotes

    • * The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • § To whom correspondence should be addressed. Tel.: 44-181-959-3666 (ext. 2465); Fax: 44-181-913-8529; E-mail:a-ager{at}nimr.mrc.ac.uk.

    • 2 Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., Boyce, R. W., Nelson, N., Kozlosky, C., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J., and Black, R. A. (1998) Science 282, 1281–1284.

    • 3 G. S. Butler and G. Murphy, unpublished observations.

    • 4 G. Borland, G. Murphy, and A. Ager, unpublished observations.

    • Abbreviations:
      TIMP

      tissue inhibitor of metalloproteinases

      MMP

      matrix metalloproteinase

      TNF-α

      tumor necrosis factor-α

      ADAM

      a disintegrin and metalloproteinase

      PMA

      phorbol myristate acetate

      LPS

      lipopolysaccharide

      PBS

      phosphate-buffered saline

      CMF

      calcium- and magnesium-free

      PBMC

      peripheral blood mononuclear cells

      FCS

      fetal calf serum

      FACS

      fluorescence-activated cell sorter

      ELISA

      enzyme-linked immunosorbent assay

      MT-MMP

      membrane-type matrix metalloproteinase

      ACE

      angiotensin-converting enzyme

      TACE

      TNF-α-converting enzyme.

      • Received August 10, 1998.
      • Revision received October 14, 1998.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement